Limitation of myocardial infarct size by nicorandil after sustained ischemia in pigs

Journal of Cardiovascular Pharmacology

Volumn 26, Issue 3, 1995, Pages 477-484

  Galiè, Nazzareno ^a   Guarnieri, Carlo ^b   Ussia, Gian Paolo ^a   Zimarino, Marco ^a   Traini, Anna Maria ^a   Parlangeli, Riccardo ^a   Vaona, Isabella ^b   Branzi, Angelo ^a   Magnani, Bruno ^a  

^a Department of Clinical and Experimental Medicine   (Italy)

^b UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

Isosorbide; Myocardial infarction; Nicorandil; Potassium channel openers

Indexed keywords

ISOSORBIDE DINITRATE; NICORANDIL; POTASSIUM CHANNEL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CORONARY HEMODYNAMICS; HEART INFARCTION; HEART INFARCTION SIZE; HEART MUSCLE ISCHEMIA; HEART MUSCLE OXYGEN CONSUMPTION; HEART MUSCLE REPERFUSION; HEART OUTPUT; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; REPERFUSION INJURY;

ANIMAL; BLOOD PRESSURE; CARDIAC OUTPUT; COMPARATIVE STUDY; FEMALE; GLUTATHIONE; HEART RATE; ISOSORBIDE DINITRATE; MALE; MALONDIALDEHYDE; MYOCARDIAL INFARCTION; MYOCARDIAL ISCHEMIA; MYOCARDIUM; NIACINAMIDE; NICORANDIL; PEROXIDASE; POTASSIUM CHANNELS; PULMONARY WEDGE PRESSURE; SWINE; VASCULAR RESISTANCE; VASODILATOR AGENTS; VENTRICULAR FUNCTION, LEFT;

EID: 0029121979     PISSN: 01602446     EISSN: 15334023     Source Type: Journal    
DOI: 10.1097/00005344-199509000-00019     Document Type: Article

References (40)

1. Taira N Satoh K, Yanagisawa T et al. Pharmacological profile of a new coronary vasodilator drug, 2-nicotinami-doethil nitrate (SG-75). Clin Exp Pharmacol Physiol 1979;6:301-316.
2. Yanagisawa T, Satoh K, Taira N. Circumstantial evidence for increased potassium conductance of membrane of cardiac muscle by 2-nicotinamidoethil nitrate (SG-75). Jpn J Pharmacol 1979;29:687-694.
3. Yanagisawa T, Taira N. Effect of 2-nicotinamidoethil nitrate (SG-75) on the membrane potential of left atrium muscle fibres of the dog. Naunyn Schmiedebergs Arch Pharmacol 1980;312:69-76.
4. Lamping KA, Gross GJ. Improved recovery of myocardial segment function following a short coronary occlusion in dogs by nicorandil, a potential new antianginal agent, and nifedipine. J Cardiovasc Pharmacol 1985;7:158-166.
5. Shimshak TM, Preuss KC, Gross GJ, et al. Recovery of contractile function in postischaemic reperfused myocardium of conscious dogs: influence of nicorandil, a new antianginal agent. Cardiovasc Res 1986;20:621-626.
6. Pieper GM, Gross GJ. Salutary action of nicorandil, a new antianginal drug, on myocardial metabolism during ischemia and on postischemic function in a canine preparation of brief, repetitive coronary artery occlusions: comparison with isosorbide dinitrate. Circulation 1987;76:916-928.
7. Gross GJ, Pieper G, Farber NE, Warltier D, Hardman H. Effects of nicorandil on coronary circulation and myocardial ischemia. Am J Cardiol 1989;63:11J-17J.
8. Lamping KA, Christensen CW, Pele LR, Warltier DC, Gross GJ. Effects of nicorandil and nifedipine on protection of ischemic myocardium. J Cardiovasc Pharmacol 1984;6:536-542.
9. Endo T, Nejima J, Kiuchi K, Fujita S, Kikuchi K, Hayakawa H, Okumura H. Reduction of size of myocardial infarction with nicorandil, a new antianginal drug, after coronary artery occlusion in dogs. J Cardiovasc Pharmacol 1988;12:587-592.
10. Auchampach JA, Gross GJ. Anti-ischaemic actions of potassium channel openers in experimental myocardial ischemia/reperfusion injury in dogs. Eur Heart J 1993;14(suppl B):10-15.
11. Hashimoto K, Ohbayashi Y, Kinoshita M. Left ventricular effects of nicorandil in comparison with nitroglycerin in chronic conscious dogs. Cardiovasc Drugs Ther 1990;4: 1449-1454.
12. Pieper GM, Gross GJ. Anti-free-radical and neutrophil-modulating properties of the nitrovasodilator, nicorandil. Cardiovasc Drugs Ther 1992;6:225-232.
13. Orita H, Shimanuki T, Fukasawa M, Abe H, Kuraoka S, Hirooka S, Washio M. Accelerated myocardial metabolic and functional recovery with terminal nicorandil-mg cardioplegia in heart transplantation. Cardiovasc Drugs Ther 1991;5:727-732.
14. +channels in cardiac muscle. Nature 1983;305:147-8.
15. +channels openers and "natural" cardioprotection. Trends Pharmacol Sci 1992;13:269-272.
16. Escande D, Henry P. Potassium channels as pharmacological targets in cardiovascular medicine. Eur Heart J 1993; 14(suppl B):2-9.
17. Grover GJ. Protective effects of ATP-sensitive potassium-channel openers in experimental myocardial ischemia. J Cardiovasc Pharmacol 1994;24:S18-S27.
18. Sassen LMA, Soli LK, Heere TJM, van Woerkens LJ, Saxena PR, Verdouw PD. Nicorandil and cardiovascular performance in anaesthetized pigs with a concentric coronary artery stenosis. Naunyn Schmiedebergs Arch Pharmacol 1989;340:733-739.
19. Galié N, Traini AM, Ussia GP, Guarnieri C, Branzi A, Magnani B. Limitation of myocardial infarct size by nicorandil in open chest pigs. J Mol Cell Cardiol 1993;25(suppl 1):S53.
20. Klein HH, Pich S, Lindert-Heimberg S, Maisch B, Nebendahl K. Comparative study on direct myocardial effects of nicorandil and nitroglycerin in ischemic, reperfused porcine hearts [abstract]. Eur Heart J 1994;15(suppl):16.
21. Eckstein RW. Coronary interarterial anastomoses in young pigs and mongrel dogs. Circ Res 1954;2:460-5.
22. Garcia-Dorado D, Theroux P, Elizaga J, et al. Myocardial reperfusion in the pig heart model: infarct size and duration of coronary occlusion. Cardiovasc Res 1987;21:537-544.
23. Klein HH, Stier A, Pich S, et al. Postischemic cell death in reperfused porcine hearts is not attenuated by the spin trap agent PBN during early reperfusion. Basic Res Cardiol 1993;88:212-222.
24. Koning MMG, Simonis LAJ, de Zeeuw S, Nieukoop S, Post S, Verdouw PD. Ischemic preconditioning by partial occlusion without intermittent reperfusion. Cardiovasc Res 1994; 28:1146-1151.
25. Bradley PP, Priebat DA, Christensen RD, Rothsein G. Measurement of cutaneous inflammation: estimation of neutrophil content with an enzyme marker. J Invest Dermatol 1982;78:206-209.
26. Mullane KM, Kraemer R, Smith B. Myeloperoxidase activity as a quantitative assessment of neutrophil infiltration into ischemic myocardium. J Pharmacol Methods 1985;14:157-167.
27. Grisham MB, Benoet JN, Granger ND. Assessment of leukocyte involvement during ischemia and reperfusion of intestine. Methods Enzymol 1990;186:729-742.
28. Tsushida M, Miura T, Mizutarri K, Aibara K. Fluorescent substances in mouse and human sera as a parameter of in vivo lipid peroxidation. Biochim Biophys Acta 1986;834:196-204.
29. Ursini F, Maiani G, Polito M, Coassin M, Ferro-Luzzi A. TBA reactive material in human plasma and its relation to nutritional parameters. Nutrition Reports International 1989;39:1263-1274.
30. Guarnieri C, Fraticelli A, Ventura C, Vaona I, Budini R. External GSSG enhances intracellular glutathione level in isolated cardiac myocytes. Biochem Biophys Res Comm 1987;147:658-665.
31. Auchampach JA, Gross GJ. Reduction in myocardial infarct size by the new potassium channel opener bimakalim. J Cardiovasc Pharmacol 1994;23:554-561.
32. Rohmann S, Weygandt H, Schelling P, et al. Effect of bimakalim (EMD 52692), an opener of ATP sensitive potassium channels, on infarct size, coronary blood flow, regional wall function, and oxygen consumption in swine. Cardiovasc Res 1994;28:858-863.
33. Yao Z, Gross GJ. Effects of KAXP channel opener bimakalim on coronary blood flow, monophasic action potential duration, and infarct size in dogs. Circulation 1994;89:1769-1775.
34. Myers RW, Scherer LJ, Goldstein RA, Goldstein RE, Kent KM, Epstein SE. Effects of nitroglycerin and nitroglycerin-methoxamine during acute myocardial ischemia in dogs with pre-existing multivessel coronary occlusive disease. Circulation 1975;51:632-640.
35. Smith ER, Redwood DR, McCarron WE, Epstein SE. Coronary artery occlusion in the conscious dog. Effects of alterations in arterial pressure produced by nitroglycerin, haemorrhage, and alpha-adrenergic agonists on the degree of myocardial ischemia. Circulation 1973;47:51-60.
36. Sakai K, Shiraki Y, Nabata H. Cardiovascular effects of a new coronary vasodilator N-(2-hydroxyethyl)nicotinamide nitrate (SG-75): comparison with nitroglycerin and diltiazem. J Cardiovasc Pharm 1981;3:139-150.
37. Gross GJ, Auchampach JA. Blockade of ATP-sensitive potassium channels prevents myocardial preconditioning in dogs. Circ Res 1992;70:223-233.
38. Perry MA, Granger DN. Role of CD11/CD18 in shear rate-dependent leukocyte-endothelial cell interactions in cat mesenteric venules. J Clin Invest 1991;87:1798-1804.
39. Garlick PB, Davies MJ, Hearse DJ, Slater TF. Direct detection of free radicals in the reperfused rat heart using electron spin resonance spectroscopy. Circ Res 1987;61:757-760.
40. Bolli R, Patel BS, Jeroudi MO, Lai EK, McCay PB. Demonstration of free radical generation in "stunned" myocardium of intact dogs with the use of the spin trap α-phenyl N-tert-butyl nitrone. J Clin Invest 1988;82:476-485.